Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
1.
Exp Cell Res ; 356(2): 136-140, 2017 07 15.
Artigo em Inglês | MEDLINE | ID: mdl-28315667

RESUMO

The hypoxia inducible factors (HIFs) promote changes in gene expression in response to hypoxia, and mediate key physiological responses such as angiogenesis. They play important roles in development and normal physiology, as well as in ischaemic and other pathologies. The human eye is a complex organ, with tight regulation of vascularisation and oxygen delivery, with the highly specialised retina containing both highly vascularised and avascular regions. This review, written to honour the significant contribution of Lorenz Poellinger to this field, covers the role of the HIFs in normal development of the eye, specifically the vasculature, as well as their roles in numerous retinal pathologies, including ischaemic retinopathies, and age-related macular degeneration (AMD). The characterisation of the HIFs in the eye has improved our understanding of the development, function, and numerous pathologies of the eye, and should inform future therapeutic approaches.


Assuntos
Hipóxia Celular/fisiologia , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Neovascularização Patológica/metabolismo , Retina/metabolismo , Doenças Retinianas/metabolismo , Animais , Humanos , Fator A de Crescimento do Endotélio Vascular/metabolismo
2.
Clin Exp Allergy ; 47(8): 1007-1013, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28390083

RESUMO

BACKGROUND: The major trigger of asthma exacerbations is infection with a respiratory virus, most commonly rhinovirus. Type 2 inflammation is known to be associated with an increased risk of exacerbations in general. Whether type 2 inflammation at baseline increases the risk of future virus-induced exacerbations is unknown. OBJECTIVE: To assess whether type 2 inflammation is associated with an increased risk of virus-induced exacerbations of asthma. METHODS: Stable asthmatics had spirometry, skin prick test, measurement of FeNO and sputum induced for differential cell counts. Patients were followed up for 18 months, during which they were assessed at the research unit when they had symptoms of an exacerbation. Nasal swabs collected at these assessments underwent viral detection by PCR. RESULTS: A total of 81 asthma patients were recruited, of which 22 (27%) experienced an exacerbation during the follow-up period. Of these, 15 (68%) had a respiratory virus detected at exacerbation. Sputum eosinophils >1% at baseline increased the risk of having a subsequent virus-induced exacerbation (HR 7.6 95% CI: 1.6-35.2, P=.010) as did having FeNO >25 ppb (HR 3.4 95% CI: 1.1-10.4, P=.033). CONCLUSION AND CLINICAL RELEVANCE: Established type 2 inflammation during stable disease is a risk factor for virus-induced exacerbations in a real-life setting. Measures of type 2 inflammation, such as sputum eosinophils and FeNO, could be included in the risk assessment of patients with asthma in future studies.


Assuntos
Asma/metabolismo , Asma/virologia , Eosinófilos/metabolismo , Óxido Nítrico/metabolismo , Escarro/metabolismo , Viroses/metabolismo , Adulto , Asma/patologia , Testes Respiratórios , Eosinófilos/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Viroses/patologia
4.
Br J Ophthalmol ; 90(2): 237-41, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16424541

RESUMO

The authors propose that light entering the eye interacts with retinal ganglion cell (RGC) axon mitochondria to generate reactive oxygen intermediates (ROI) and that when these neurons are in an energetically low state, their capacity to remove these damaging molecules is exceeded and their survival is compromised. They suggest that in the initial stages of glaucoma, RGCs exist at a low energy level because of a reduced blood flow at the optic nerve head and that in the mitochondrial optic neuropathies (MONs), this results from a primary, genetic defect in aerobic metabolism. In these states RGCs function at a reduced energy level and incident light on the retina becomes a risk factor. Preliminary laboratory studies support this proposition. Firstly, the authors have shown that light is detrimental to isolated mitochondria in an intensity dependent manner. Secondly, light triggers apoptosis of cultured, transformed RGCs and this effect is exacerbated when the cells are nutritionally deprived. Detailed studies are under way to strengthen the proposed theory. On the basis of this proposal, the authors suggest that patients with optic neuropathies such as glaucoma or at risk of developing a MON may benefit from the use of spectral filters and reducing the intensity of light entering the eye.


Assuntos
Glaucoma/metabolismo , Luz/efeitos adversos , Mitocôndrias/efeitos da radiação , Doenças do Nervo Óptico/metabolismo , Células Ganglionares da Retina/efeitos da radiação , Apoptose/efeitos da radiação , Humanos , Mitocôndrias/metabolismo , Disco Óptico/irrigação sanguínea , Doenças do Nervo Óptico/genética , Espécies Reativas de Oxigênio/metabolismo , Fluxo Sanguíneo Regional , Células Ganglionares da Retina/metabolismo , Fatores de Risco
5.
Forensic Sci Int ; 254: 133-47, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26232846

RESUMO

A more comprehensive understanding of the variability of latent fingermark composition is essential to improving current fingermark detection capabilities in an informed manner. Gas chromatography-mass spectrometry was used to examine the composition of the lipid fraction of latent fingermarks collected from a population of over 100 donors. Variations in the appearances of chromatograms from different donors were apparent in the relative peak sizes of compounds including free fatty acids, squalene, cholesterol and wax esters. Principal component analysis was used as an exploratory tool to explore patterns in this variation, but no correlation to donor traits could be discerned. This study also highlights the practical and inherent difficulties in collecting reproducible samples.


Assuntos
Dermatoglifia , Lipídeos/análise , Sebo/química , Adulto , Feminino , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Masculino , Análise de Componente Principal , Adulto Jovem
6.
Neuropharmacology ; 45(5): 637-48, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12941377

RESUMO

The main aim of this study was to investigate whether intraocular injection of low concentrations of zinc (no greater than 10 microM) aid the survival of ganglion cells in the rat retina after excitotoxic (NMDA) and ischemia/reperfusion injuries. We also determined whether low amounts of zinc cause any detectable retinal toxicity. Intraocular injection of NMDA caused substantial reductions in the mRNA levels of the ganglion cell-specific markers Thy-1 and neurofilament light (NF-L). Co-injection of 0.1 or 1 nmol zinc neither diminished nor exacerbated the effect of NMDA on the levels of these mRNAs. Likewise, ischemia/reperfusion caused significant decreases in the levels of Thy-1 and NF-L mRNAs and in the b-wave amplitude of the electroretinogram. These effects were not counteracted by injection of zinc. Intraocular injection of NMDA caused marked toxicological effects in retinal glial cells, including upregulations of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), glial fibrial acidic protein (GFAP), basic fibroblast growth factor (FGF-2) and ciliary neurotrophic factor (CNTF). Interestingly, injection of 1 nmol zinc caused no changes in the levels of COX-2 and iNOS, yet produced similar, although quantitatively less pronounced, changes in FGF-2, GFAP and CNTF. The upregulations of FGF-2 and CNTF suggest that increasing zinc intake may benefit injured retinal neurons. However, this was not found to be the case in the present studies, perhaps due to the acute nature of the injury paradigms utilised.


Assuntos
Adstringentes/farmacologia , Retina/efeitos dos fármacos , Células Ganglionares da Retina/efeitos dos fármacos , Sulfato de Zinco/farmacologia , Animais , Morte Celular , Sobrevivência Celular/efeitos dos fármacos , Fator Neurotrófico Ciliar/genética , Ciclo-Oxigenase 2 , Maleato de Dizocilpina/farmacologia , Relação Dose-Resposta a Droga , Interações Medicamentosas , Eletrorretinografia/instrumentação , Eletrorretinografia/métodos , Agonistas de Aminoácidos Excitatórios/toxicidade , Antagonistas de Aminoácidos Excitatórios/farmacologia , Olho , Fator 2 de Crescimento de Fibroblastos/genética , Fator 2 de Crescimento de Fibroblastos/metabolismo , Proteína Glial Fibrilar Ácida/genética , Proteína Glial Fibrilar Ácida/metabolismo , Immunoblotting , Imuno-Histoquímica , Isoenzimas/genética , N-Metilaspartato/toxicidade , Neuroglia/efeitos dos fármacos , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase/imunologia , Óxido Nítrico Sintase Tipo I , Óxido Nítrico Sintase Tipo II , Prostaglandina-Endoperóxido Sintases/genética , RNA Mensageiro/biossíntese , Ratos , Ratos Wistar , Traumatismo por Reperfusão/genética , Traumatismo por Reperfusão/metabolismo , Traumatismo por Reperfusão/fisiopatologia , Retina/citologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Rodopsina/genética , Rodopsina/metabolismo , Antígenos Thy-1/genética , Fatores de Tempo
7.
Neuropharmacology ; 43(6): 1015-25, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12423671

RESUMO

The aim of this study was to examine whether the antioxidant alpha-lipoic acid protects retinal neurons from ischemia-reperfusion injury. Rats were injected intraperitoneally with either vehicle or alpha-lipoic acid (100 mg/kg) once daily for 11 days. On the third day, ischemia was delivered to the rat retina by raising the intraocular pressure above systolic blood pressure for 45 min. The electroretinogram was measured prior to ischemia and 5 days after reperfusion. Rats were killed 5 or 8 days after reperfusion and the retinas were processed for immunohistochemistry and for determination of mRNA levels by RT-PCR. Ischemia-reperfusion caused a significant reduction of the a- and b-wave amplitudes of the electroretinogram, a decrease in nitric oxide synthase and Thy-1 immunoreactivities, a decrease of retinal ganglion cell-specific mRNAs and an increase in bFGF and CNTF mRNA levels. All of these changes were clearly counteracted by alpha-lipoic acid. Moreover, in mixed rat retinal cultures, alpha-lipoic acid partially counteracted the loss of GABA-immunoreactive neurons induced by anoxia. The results of the study demonstrate that alpha-lipoic acid provides protection to the retina as a whole, and to ganglion cells in particular, from ischemia-reperfusion injuries. alpha-Lipoic acid also displayed negligible affinity for voltage-dependent sodium and calcium channels.


Assuntos
Antioxidantes/uso terapêutico , Traumatismo por Reperfusão/tratamento farmacológico , Doenças Retinianas , Doenças Retinianas/tratamento farmacológico , Ácido Tióctico/uso terapêutico , Anestésicos Locais/farmacologia , Animais , Ligação Competitiva , Fator Neurotrófico Derivado do Encéfalo/efeitos dos fármacos , Fator Neurotrófico Derivado do Encéfalo/genética , Cálcio/metabolismo , Bloqueadores dos Canais de Cálcio/farmacocinética , Células Cultivadas , Fator Neurotrófico Ciliar/efeitos dos fármacos , Fator Neurotrófico Ciliar/genética , Primers do DNA , Diltiazem/farmacologia , Maleato de Dizocilpina/farmacologia , Relação Dose-Resposta a Droga , Interações Medicamentosas , Eletrorretinografia/efeitos dos fármacos , Fatores de Crescimento de Fibroblastos/efeitos dos fármacos , Fatores de Crescimento de Fibroblastos/genética , Proteína Glial Fibrilar Ácida/efeitos dos fármacos , Proteína Glial Fibrilar Ácida/genética , Gliceraldeído-3-Fosfato Desidrogenases/efeitos dos fármacos , Gliceraldeído-3-Fosfato Desidrogenases/metabolismo , N-Metilaspartato/farmacologia , Nifedipino/farmacocinética , RNA Mensageiro/biossíntese , Ratos , Traumatismo por Reperfusão/fisiopatologia , Doenças Retinianas/fisiopatologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Rodopsina/efeitos dos fármacos , Rodopsina/metabolismo , Sódio/metabolismo , Tetrodotoxina/farmacologia , Antígenos Thy-1/metabolismo , Veratridina/farmacologia
8.
Neuroscience ; 87(3): 675-89, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9758233

RESUMO

Serotonin is thought to play a physiological role in various tissues of the rabbit eye, yet little is known about the relative distribution of the different serotonin receptors. Demonstration of the receptor subtypes present in the various ocular tissues is essential in order to understand the function of serotonin in the eye. Using a combination of in situ hybridization histochemistry, in vitro receptor autoradiography and polymerase chain reaction studies, we have explored the distribution of the 5-hydroxytryptamine1A and 5-hydroxytryptamine7 receptors in the rabbit eye. As these receptors have not been sequenced in the rabbit, we initially established the suitability of the oligonucleotide probes by analysis of brain tissue. The distributions of 5-hydroxytryptamine1A and 5-hydroxytryptamine7 receptor messenger RNAs in rabbit brain correlated well with those in other species, confirming the specificity of the probes for detection of the messenger RNAs in rabbit tissues. In the eye, the expression of 5-hydroxytryptamine1A receptors appears to be restricted to the epithelial cell layer of the ciliary processes, although very low levels may appear in the retina. In contrast, the expression of 5-hydroxytryptamine7 receptor messenger RNA is more widespread with positive signals evident in the ciliary processes, retina and iris. The results confirm the existence of 5-hydroxytryptamine1A receptors in the ciliary body and their localization in the ciliary epithelium supports the hypothesis that they are involved in the secretion of aqueous humour. Unexpectedly, there was little evidence to support the idea that 5-hydroxytryptamine1A receptors are present in the retina and iris sphincter. However, the subsequent finding of 5-hydroxytryptamine7 receptor messenger RNA in the retina and iris may explain the apparent absence of 5-hydroxytryptamine1A receptors in these tissues. The presence of both 5-hydroxytryptamine1A and 5-hydroxytryptamine7 receptors in the ciliary processes may account for the complex intraocular pressure response of the rabbit to serotonin.


Assuntos
Química Encefálica/fisiologia , Receptores de Serotonina/análise , Retina/química , 8-Hidroxi-2-(di-n-propilamino)tetralina/farmacologia , Animais , Corpo Ciliar/química , Córnea/química , Expressão Gênica , Hipocampo/química , Cristalino/química , Piperazinas/farmacologia , Piridinas/farmacologia , RNA Mensageiro/análise , Coelhos , Ensaio Radioligante , Receptores de Serotonina/genética , Receptores 5-HT1 de Serotonina , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Antagonistas da Serotonina/farmacologia , Agonistas do Receptor de Serotonina/farmacologia , Trítio
9.
Invest Ophthalmol Vis Sci ; 36(11): 2238-45, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7558717

RESUMO

PURPOSE: This study sought to identify, characterize, and localize subtypes of 5-hydroxytryptamine (HT) receptors in rabbit iris-ciliary body. METHODS: Radioligand binding assays were performed with [3H]5-hydroxytryptamine on membranes prepared from rabbit iris-ciliary bodies and on tissue sections subsequently developed by autoradiography. RESULTS: [3H]5-HT appeared to bind to a single population of receptors in membrane preparations of rabbit iris-ciliary body. The apparent affinity of the ligand (KD) was 2.19 nM, and the density of binding sites was 58.3 fmol/mg protein. Binding of [3H] 5-HT exhibited guanosine-5-triphosphate sensitivity. Competitive inhibition experiments were performed to differentiate between 5-HT receptor subtypes. A relative potency order of 5-CT > 5-HT = 8-OH-DPAT > ipsapirone > RU24969 > sumatriptan > ritanserin > ketanserin was demonstrated. The apparent inhibitory constants for the ligands tested fit with the profile expected of binding to 5-HT1A receptors. Inhibition studies with [3H] 5-HT plus 100 nM 8-OH-DPAT (which inhibits binding to 5-HT1A receptors only) representing total binding, indicated that no further displacement occurred when ligands preferentially selective for 5-HT1B, 5-HT1D alpha,1D beta, or 5-HT2C were tested. Total binding of [3H] 5-HT in tissue sections developed by autoradiography was displaced completely by 100 nM 8-OH-DPAT. Melatonin showed little affinity for the [3H] 5-HT binding sites. CONCLUSIONS: A population of 5-HT1A receptors is present in rabbit ciliary processes. There is no evidence to suggest the presence of 5-HT1D alpha, 5-HT1D beta, 5-HT2B, or 5-HT2C receptors in the iris-ciliary body.


Assuntos
Corpo Ciliar/metabolismo , Iris/metabolismo , Receptores de Serotonina/metabolismo , Serotonina/metabolismo , Animais , Autorradiografia , Ligação Competitiva/efeitos dos fármacos , Membrana Celular/metabolismo , Melatonina/farmacologia , Coelhos , Ensaio Radioligante , Antagonistas da Serotonina/farmacologia , Agonistas do Receptor de Serotonina/farmacologia
10.
Br J Pharmacol ; 130(4): 759-66, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10864881

RESUMO

Betaxolol, a beta(1)-adrenoceptor antagonist used for the treatment of glaucoma, is known to be neuroprotective in paradigms of ischaemia/excitotoxicity. In this study, we examined whether betaxolol and other beta-adrenoceptor antagonists interact directly with neurotoxin binding to sites 1 and 2 of the voltage-sensitive sodium channel (Na(+) channel) in rat cerebrocortical synaptosomes. Betaxolol inhibited specific [(3)H]-batrachotoxinin-A 20-alpha-benzoate ([(3)H]-BTX-B) binding to neurotoxin site 2 in a concentration-dependent manner with an IC(50) value of 9.8 microM. Comparison of all the beta-adrenoceptor antagonists tested revealed a potency order of propranolol>betaxolol approximately levobetaxolol>levobunolol approximately carteolol>/=timolol>atenolol. None of the drugs caused a significant inhibition of [(3)H]-saxitoxin binding to neurotoxin receptor site 1, even at concentrations as high as 250 microM. Saturation experiments showed that betaxolol increased the K(D) of [(3)H]-BTX-B binding but had no effect on the B(max). The association kinetics of [(3)H]-BTX-B were unaffected by betaxolol, but the drug significantly accelerated the dissociation rate of the radioligand. These findings argue for a competitive, indirect, allosteric mode of inhibition of [(3)H]-BTX-B binding by betaxolol. Betaxolol inhibited veratridine-stimulated Na(+) influx in rat cortical synaptosomes with an IC(50) value of 28. 3 microM. Carteolol, levobunolol, timolol and atenolol were significantly less effective than betaxolol at reducing veratridine-evoked Na(+) influx. The ability of betaxolol to interact with neurotoxin site 2 of the Na(+) channel and inhibit Na(+) influx may have a role in its neuroprotective action in paradigms of excitotoxicity/ischaemia and in its therapeutic effect in glaucoma.


Assuntos
Antagonistas Adrenérgicos beta/farmacologia , Betaxolol/farmacologia , Córtex Cerebral/efeitos dos fármacos , Canais de Sódio/efeitos dos fármacos , Sódio/metabolismo , Sinaptossomos/efeitos dos fármacos , Antagonistas de Receptores Adrenérgicos beta 1 , Antagonistas Adrenérgicos beta/metabolismo , Animais , Atenolol/farmacologia , Batraquiotoxinas/metabolismo , Ligação Competitiva/efeitos dos fármacos , Carteolol/farmacologia , Córtex Cerebral/metabolismo , Relação Dose-Resposta a Droga , Cinética , Levobunolol/farmacologia , Membranas/efeitos dos fármacos , Membranas/metabolismo , Propranolol/farmacologia , Ratos , Ratos Wistar , Saxitoxina/metabolismo , Canais de Sódio/metabolismo , Radioisótopos de Sódio , Sinaptossomos/metabolismo , Timolol/farmacologia , Trítio
11.
Surv Ophthalmol ; 43 Suppl 1: S102-28, 1999 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10416754

RESUMO

Management of glaucoma is directed at the control of intraocular pressure (IOP), yet it is recognized now that increased IOP isjust an important risk factor in glaucoma. Therapy that prevents the death of ganglion cells is the main goal of treatment, but an understanding of the causes of ganglion cell death and precisely how it occurs remains speculative. Present information supports the working hypothesis that ganglion cell death may result from a particular form of ischemia. Support for this view comes from the fact that not all types of retinal ischemia lead to the pathologic findings seen in glaucomatous retinas or to cupping in the optic disk area. Moreover, in animal experiments in which ischemia is caused by elevated IOP, a retinal abnormality similar to that seen in true glaucoma is produced, whereas after occlusion of the carotid arteries a different pattern of damage is found. In ischemia, glutamate is released, and this initiates the death of neurons that contain ionotropic glutamate (NMDA) receptors. Elevated glutamate levels exist in the vitreous humor of patients with glaucoma, and NMDA receptors exist on ganglion cells and a subset of amacrine cells. Experimental studies have shown that a variety of agents can be used to prevent the death of retinal neurons (particularly ganglion cells) induced by ischemia. These agents are generally those that block NMDA receptors to prevent the action of the released glutamate or substances that interfere with the subsequent cycle of events that lead to cell death. The major causes of cell death after activation of NMDA receptors are the influx of calcium into cells and the generation of free radicals. Substances that prevent this cascade of events are, therefore, often found to act as neuroprotective agents. For a substance to have a role as a neuroprotective agent in glaucoma, it would ideally be delivered topically to the eye and used repeatedly. It is, therefore, of interest that betaxolol, a beta-blocker presently used to reduce IOP in humans, also has calcium channel-blocking functions. Moreover, experimental studies show that betaxolol is an efficient neuro protective agent against retinal ischemia in animals, when injected directly into the eye or intraperitoneally.


Assuntos
Glaucoma/complicações , Isquemia/tratamento farmacológico , Fármacos Neuroprotetores/uso terapêutico , Doenças Retinianas/tratamento farmacológico , Antagonistas Adrenérgicos beta/uso terapêutico , Animais , Apoptose/efeitos dos fármacos , Bloqueadores dos Canais de Cálcio/uso terapêutico , Glaucoma/tratamento farmacológico , Glaucoma/patologia , Humanos , Pressão Intraocular , Isquemia/etiologia , Isquemia/patologia , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Doenças Retinianas/etiologia , Doenças Retinianas/patologia , Células Ganglionares da Retina/efeitos dos fármacos , Células Ganglionares da Retina/metabolismo , Células Ganglionares da Retina/patologia , Resultado do Tratamento
12.
Brain Res ; 877(1): 47-57, 2000 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-10980242

RESUMO

alpha(2)-adrenoceptor agonists, such as clonidine, attenuate hypoxia-induced damage to brain and retinal neurones by a mechanism of action which likely involves stimulation of alpha(2)-adrenoceptors. In addition, the neuroprotective effect of alpha(2)-adrenoceptor agonists in the retina may involve stimulation of bFGF production. The purpose of this study was to examine more thoroughly the neuroprotective properties of clonidine. In particular, studies were designed to ascertain whether clonidine acts as a free radical scavenger. It is thought that betaxolol, a beta(1)-adrenoceptor antagonist, acts as a neuroprotective agent by interacting with sodium and L-type calcium channels to reduce the influx of these ions into stressed neurones. Studies were therefore undertaken to determine whether clonidine has similar properties. In addition, studies were undertaken to determine whether i.p. injections of clonidine or betaxolol affect retinal bFGF mRNA levels. In vitro data were generally in agreement that clonidine and bFGF counteracted the effect of NMDA as would occur in hypoxia. No evidence could be found that clonidine interacts with sodium or L-type calcium channels, reduces calcium influx into neurones or acts as a free radical scavenger at concentrations below 100 microM. Moreover, i.p. injection of clonidine, but not betaxolol, elevated bFGF mRNA levels in the retina. The conclusion from this study is that the neuroprotective properties of alpha(2)-adrenoceptor agonists, like clonidine, are very different from betaxolol. The fact that both betaxolol and clonidine blunt hypoxia-induced death to retinal ganglion cells suggests that combining the two drugs may be a way forward to producing more effective neuroprotection.


Assuntos
Agonistas alfa-Adrenérgicos/farmacologia , Clonidina/farmacologia , Fator 2 de Crescimento de Fibroblastos/farmacologia , Retina/efeitos dos fármacos , Antagonistas Adrenérgicos beta/farmacologia , Animais , Batraquiotoxinas/metabolismo , Betaxolol/farmacologia , Bloqueadores dos Canais de Cálcio/metabolismo , Córtex Cerebral/metabolismo , Embrião de Galinha , Fator 2 de Crescimento de Fibroblastos/fisiologia , Fármacos Neuroprotetores/farmacologia , Neurotoxinas/metabolismo , Nitrendipino/metabolismo , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/metabolismo , Coelhos , Ratos , Ratos Wistar , Espécies Reativas de Oxigênio/fisiologia , Retina/metabolismo , Saxitoxina/metabolismo , Canais de Sódio/efeitos dos fármacos , Canais de Sódio/metabolismo
13.
Eur J Pharmacol ; 406(3): 319-24, 2000 Oct 20.
Artigo em Inglês | MEDLINE | ID: mdl-11040337

RESUMO

The present study was undertaken to determine whether 5-hydroxytryptamine(1A) (5-HT(1A)) receptor agonists interact with voltage-sensitive Na(+) or N- and P/Q-type Ca(2+) channels to reduce the influx of Na(+) and/or Ca(2+). The 5-HT(1A) receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibited both [3H]batrachotoxinin binding to neurotoxin site 2 of the Na(+) channel in rat cortical membranes (IC(50)=5.1 microM) and veratridine-stimulated Na(+) influx into rat synaptosomes (EC(50)=20. 8 microM). The 5-HT(1A) receptor agonist flesinoxan and the 5-HT(1A) receptor antagonist N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexanecarboxamide (WAY-100635) also displaced [3H]batrachotoxinin binding with similar affinities to 8-OH-DPAT, but were much less effective in reducing veratridine-stimulated Na(+) influx. All three serotonergic agents also increased [3H]saxitoxin binding to neurotoxin site 1 of the Na(+) channel. In contrast, none of these agents interacted with radioligand binding to N- or P/Q-type Ca(2+) channels. These data show that 8-OH-DPAT directly interacts with voltage-sensitive Na(+) channels to reduce Na(+) influx so providing an additional mechanism to explain how it functions as a neuroprotectant.


Assuntos
8-Hidroxi-2-(di-n-propilamino)tetralina/farmacologia , Fármacos Neuroprotetores/farmacologia , Agonistas do Receptor de Serotonina/farmacologia , Bloqueadores dos Canais de Sódio , Animais , Batraquiotoxinas/metabolismo , Cálcio/metabolismo , Piperazinas/farmacologia , Piridinas/farmacologia , Ratos , Saxitoxina/metabolismo , Sódio/metabolismo , ômega-Conotoxinas/metabolismo
14.
Brain Res Bull ; 62(6): 525-8, 2004 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-15036567

RESUMO

Glaucoma is a chronic optic neuropathy in which retinal ganglion cells die over a number of years. The initiation of the disease and its progression may involve an ischaemic-like insult to the ganglion cell axons caused by an alteration in the quality of blood flow. Thus, to effectively treat glaucoma it may be necessary to counteract the ischaemic-like insult to the region of the optic nerve head. Studies on the isolated optic nerve suggest that substances that reduce the influx of sodium would be particularly effective neuroprotectants. Significantly, of the presently used antiglaucoma substances, only beta-blockers can reduce sodium influx into cells. Moreover, they also reduce the influx of calcium and this would be expected to benefit the survival of insulted neurones. Betaxolol is the most effective antiglaucoma drug at reducing sodium/calcium influx. Our electroretinographic data indicated that topical application of levobetaxolol to rats attenuated the effects of ischaemia/reperfusion injury. Timolol was also effective but to a lesser extent. Based on these data we conclude that beta-blockers may be able to blunt ganglion cell death in glaucoma, and that levobetaxolol may be a more effective neuroprotectant than timolol because of its greater capacity to block sodium and calcium influx.


Assuntos
Betaxolol/uso terapêutico , Isquemia/tratamento farmacológico , Retina/efeitos dos fármacos , Trocador de Sódio e Cálcio/antagonistas & inibidores , Timolol/uso terapêutico , Animais , Betaxolol/farmacologia , Cálcio/antagonistas & inibidores , Cálcio/metabolismo , Glaucoma/tratamento farmacológico , Glaucoma/metabolismo , Humanos , Isquemia/metabolismo , Retina/metabolismo , Sódio/antagonistas & inibidores , Sódio/metabolismo , Trocador de Sódio e Cálcio/metabolismo , Timolol/farmacologia
15.
Curr Eye Res ; 23(2): 144-53, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11840354

RESUMO

PURPOSE: alpha1-Adrenoceptor antagonists and 5-HT1A receptor agonists reduce intraocular pressure (IOP) in the rabbit. The aims of this study were firstly, to determine the IOP-lowering effects of flesinoxan and selected other hybrid 5-HT1A receptor agonists/alpha1-adrenoceptor antagonists, and secondly, to investigate the mechanism of action of the IOP response to flesinoxan. METHODS: IOP and total outflow facility were measured in rabbits after administration of hybrid drugs. Inositol phosphates accumulation assays were performed using standard methodologies. RESULTS: Topical unilateral instillation of the drugs caused dose-related reductions of IOP. Comparison of the compounds tested revealed a potency order of WB 4101 > flesinoxan > 5-methyl-urapidil > or = BMY7378 > urapidil. WB-4101 caused a small increase in total outflow facility whereas flesinoxan had no effect. Measurement of the IC50 values for inhibition of phenylephrine-stimulated inositol phosphates accumulation in rabbit iris-ciliary body revealed a potency order of WB 4101 > 5-methyl-urapidil > flesinoxan > BMY 7378 = urapidil. Topical flesinoxan was ineffective in reversing phenylephrine-induced mydriasis, yet, pretreatment with the 5-HT1A receptor antagonists MDL 73005EF and pindolol only partially blocked the hypotensive effect of topical flesinoxan. CONCLUSIONS: The present studies indicate the potent and efficacious IOP-lowering capabilities of flesinoxan and certain other ligands with affinity for 5-HT1A receptors/alpha1-adrenoceptors. The exact mechanisms by which these drugs lower IOP in the rabbit are complex but our results indicate that flesinoxan likely reduces aqueous secretion.


Assuntos
Antagonistas de Receptores Adrenérgicos alfa 1 , Pressão Intraocular/efeitos dos fármacos , Piperazinas/farmacologia , Receptores de Serotonina/metabolismo , Agonistas do Receptor de Serotonina/farmacologia , Animais , Humor Aquoso/metabolismo , Corpo Ciliar/efeitos dos fármacos , Corpo Ciliar/metabolismo , Feminino , Fosfatos de Inositol/biossíntese , Masculino , Pupila/efeitos dos fármacos , Coelhos , Receptores 5-HT1 de Serotonina
16.
Eur J Ophthalmol ; 13 Suppl 3: S19-26, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12749673

RESUMO

The primary features of glaucomatous optic neuropathy are characteristic changes in the optic nerve head, a decrease in number of surviving ganglion cells and a reduction in vision. It is now generally accepted that a number of factors, including elevated intraocular pressure, could lead to the changes seen in the optic nerve head and to obtain a pharmacological means to treat the causes will vary from patient to patient. In contrast, a cascade of events have been proposed to explain how the changes in the optic nerve head may lead to the slow and differential death of ganglion cells in the disease. It is also proposed that drugs (neuroprotectants) influencing this cascade of events can attenuate ganglion cell death and lead to the treatment of all glaucoma patients.


Assuntos
Apoptose/efeitos dos fármacos , Glaucoma/complicações , Fármacos Neuroprotetores/farmacologia , Disco Óptico/patologia , Doenças do Nervo Óptico/etiologia , Doenças do Nervo Óptico/prevenção & controle , Células Ganglionares da Retina/patologia , Animais , Citoproteção/efeitos dos fármacos , Glaucoma/patologia , Glaucoma/prevenção & controle , Humanos , Disco Óptico/efeitos dos fármacos , Doenças do Nervo Óptico/patologia , Células Ganglionares da Retina/efeitos dos fármacos
17.
J Comp Pathol ; 151(2-3): 153-6, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24973988

RESUMO

The epsilon toxin elaborated by Clostridium perfringens type D in the intestine of domestic livestock is principally responsible for the neurological disease produced after its absorption in excessive quantities into the systemic circulation. The fundamental basis of the cerebral damage induced by epsilon toxin appears to be microvascular injury with ensuing severe, diffuse vasogenic oedema. Endothelial barrier antigen (EBA), which is normally expressed by virtually all capillaries and venules in the rat brain, was used in this study as a marker of blood-brain barrier (BBB) integrity. After exposure to high levels of circulating epsilon toxin, there was substantial loss of EBA in many brain microvessels, attended by widespread plasma albumin extravasation. These results support microvascular injury and subsequent BBB breakdown as a key factor in the pathogenesis of epsilon toxin-induced neurological disease.


Assuntos
Antígenos de Superfície/análise , Toxinas Bacterianas/toxicidade , Barreira Hematoencefálica/patologia , Endotélio Vascular/patologia , Animais , Biomarcadores/análise , Infecções por Clostridium/patologia , Infecções por Clostridium/veterinária , Clostridium perfringens , Modelos Animais de Doenças , Imuno-Histoquímica , Ratos , Ratos Sprague-Dawley
18.
J Clin Neurosci ; 19(8): 1159-64, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22705132

RESUMO

Non-accidental head injury (NAHI), also termed the "shaken baby syndrome", is a major cause of death and severe neurological dysfunction in children under three years of age, but it is debated whether shaking alone is sufficient to produce brain injury and mortality or whether an additional head impact is required. In an attempt to resolve this question, we used a lamb model of NAHI since these animals have a relatively large gyrencephalic brain and weak neck muscles resembling those of a human infant. Three anaesthetised lambs of lower body weight than others in the experimental group died unexpectedly after being shaken, proving that shaking alone can be lethal. In these lambs, axonal injury, neuronal reaction and albumin extravasation were widely distributed in the hemispheric white matter, brainstem and at the craniocervical junction, and of much greater magnitude than in higher body weight lambs which did not die. Moreover, in the eyes of these shaken lambs, there was damage to retinal inner nuclear layer neurons, mild, patchy ganglion cell axonal injury, widespread Muller glial reaction, and uveal albumin extravasation. This study proved that shaking of a subset of lambs can result in death, without an additional head impact being required.


Assuntos
Modelos Animais de Doenças , Síndrome do Bebê Sacudido/patologia , Síndrome do Bebê Sacudido/fisiopatologia , Precursor de Proteína beta-Amiloide/metabolismo , Animais , Encéfalo/patologia , Proteínas de Ligação ao Cálcio , Proteínas de Ligação a DNA/metabolismo , Proteína Glial Fibrilar Ácida/metabolismo , Proteínas dos Microfilamentos , Neurônios/metabolismo , Neurônios/patologia , Retina/patologia , Ovinos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa